| Drug Name | Copiktra(DUVELISIB) |
|---|---|
| Drug Class |
Anticancer
|
| Risk minimization type |
Safety communication
|
| Specialty (Theraputic area) |
Oncology
|
| Risk |
Possible Increased Risk of Death and Serious Adverse events with Copiktra (duvelisib) Use |
| safety communication |
|